Biotechnology Letters has an established position amongst the top rapid-publication biotechnology journals offering rapid assessment of submitted papers and a wide audience for the published papers. The impact factor of the journal has steadily increased in recent years to 1.636 as have the numbers of downloads of articles that are consistently over 25000 per month suggesting a very high impact of published articles in both research groups and in industrial laboratories.
The introduction of mini-reviews in 2003 has proven to be a well-received development in the Journal and has resulted in a step-improvement in the journal's impact factor. Although most of the published reviews are invited ones, we extend this invitation to all our readers to submit a review manuscript for consideration of publication in the Journal. Some of the major reviews that we have published in recent years have provided key information on such widely-diverse topics as:
• Gene therapy of glioma cancer (Fu et al. 2010 (Haidar et al. 2009a, b) • Microalgal biotechnology (Eriksen 2008) , • Metabolic flux analysis (Iwatani et al. 2008 ), • Microbial metabolomics (Mashego et al. 2007 ), • Hyaluronic acid for biomedical and industrial applications (Kogan et al. 2007 ).
In keeping with our desire to inform the biotechnology fraternity of current developments and activities in biotechnology, we invite those readers of this Journal, who consider that their own expertise in a particular field should be shared with other likeminded researchers, to submit a mini-review to us for consideration.
Manuscripts should be submitted on-line in the usual manner and in the style that is described in the Instructions to Authors (downloadable from our website), but authors may choose to seek an initial opinion on the scope of their intended review by contacting either of the two reviews editors (david. archer@nottingham.ac.uk or danny.rangasamy@anu. edu.au). Review articles are short (normally no more than 3500 words) and should provide insight, based on a critical assessment of the literature, on topics relevant to biotechnology. We remind our readers that we now have specific sections within the Journal to cover the major aspects of biotechnology: However, we are well-aware that many key developments lie at the interface of two or more of these sections and therefore these sections are not absolute criteria for consideration of a review for inclusion in the Journal. Inter-disciplinary reviews are therefore especially welcome.
On behalf of the executive editors of Biotechnology Letters, we look forward to receiving your manuscript.
